Sino Medical Sciences Technology In

688108 · SHG · Healthcare / Medical Devices

12.93CNY-0.38 (-2.85%)

Price History

Full chart

Market Stats

Previous Close13.31

Open13.35

Day Range12.86 – 13.46

52-Week Range14.59 – 31.45

Volume5.40M

Market Cap6.21B

P/E (TTM)74.35

Forward P/E0.00

EPS0.20

Dividend Yield0.00%

Beta0.59

50-Day Avg16.58

200-Day Avg19.89

About

Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Sciences Technology Inc. was incorporated in 2007 and is headquartered in Tianjin, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Jianhua Sun
Employees729
HeadquartersTEDA Biomedical R&D Building, Tianjin, China, 300457, China
Websitehttps://www.sinomed.com

Leadership

Mr. Jianhua SunChairman & GM · b. 1961
Ms. Lihua ShenCFO & Accounting Supervisor · b. 1971
Mr. Liye CuiDeputy General Manager of Production & Operation · b. 1974
Ms. Lin ChenDirector of Human Resources & Employee Director · b. 1982
Mr. Xiaoran KangDeputy GM & Director · b. 1986
Mr. Kai HuangBoard Secretary & Director · b. 1973
Mr. Wenbin CaiR&D Director · b. 1984
Mr. Tianzhu LiCore Technical Personnel · b. 1983

Financials

Income Statement

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	265.61M	322.00M	380.42M	435.91M	327.42M	194.36M	192.85M	343.26M	458.74M	525.41M
Growth (%)	-	+21.23%	+18.14%	+14.59%	-24.89%	-40.64%	-0.77%	+77.99%	+33.64%	+14.53%
Cost of Revenue	39.11M	52.52M	68.24M	75.15M	67.10M	60.25M	85.64M	145.64M	192.64M	176.98M
Gross Profit	226.50M	269.48M	312.18M	360.76M	260.32M	134.11M	107.21M	197.62M	266.10M	525.41M
Gross Margin	85.28%	83.69%	82.06%	82.76%	79.51%	69.00%	55.59%	57.57%	58.01%	100.00%
Operating Expense	188.49M	187.14M	203.84M	252.18M	236.31M	297.38M	326.39M	267.04M	283.06M	458.60M
Operating Income	38.01M	82.35M	108.34M	108.58M	24.01M	-163.28M	-219.18M	-69.42M	-16.97M	66.80M
Operating Margin	14.31%	25.57%	28.48%	24.91%	7.33%	-84.01%	-113.65%	-20.22%	-3.70%	12.71%
EBITDA	55.83M	97.74M	123.59M	136.19M	67.29M	-108.50M	-168.43M	-13.01M	53.27M	133.04M
EBITDA Margin	21.02%	30.35%	32.49%	31.24%	20.55%	-55.82%	-87.34%	-3.79%	11.61%	25.32%
Net Income	28.65M	66.15M	89.19M	90.04M	22.49M	-130.77M	-162.38M	-39.63M	1.50M	47.29M
Net Income Margin	10.79%	20.54%	23.45%	20.65%	6.87%	-67.28%	-84.20%	-11.55%	0.33%	9.00%
R&D	76.00M	53.68M	66.55M	89.59M	108.73M	148.93M	152.80M	114.10M	140.56M	122.57M
R&D as % of Total Revenue	28.61%	16.67%	17.49%	20.55%	33.21%	76.63%	79.23%	33.24%	30.64%	23.33%
Interest Expense	0	116.84K	167.45K	162.69K	146.65K	2.36M	2.55M	3.93M	5.83M	5.05M
Interest Expense % of Total Revenue	0.00%	0.04%	0.04%	0.04%	0.04%	1.22%	1.32%	1.14%	1.27%	0.96%

Balance Sheet

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	280.81M	710.33M	806.10M	1.21B	1.22B	1.10B	1.07B	1.19B	1.30B	1.35B
Total Liabilities	78.06M	103.62M	104.83M	107.11M	139.63M	157.92M	180.13M	324.17M	402.22M	-931.81M
Total Equity	202.75M	606.70M	701.28M	1.10B	1.08B	927.84M	847.08M	819.96M	866.89M	931.81M
Cash	43.74M	107.48M	375.01M	638.38M	544.66M	287.76M	203.42M	188.64M	291.67M	396.41M
Total Debt	1.03M	1.17M	954.86K	-	50.92M	44.27M	58.31M	144.49M	126.84M	-
Net Debt	-42.70M	-106.31M	-374.05M	-638.38M	-493.75M	-243.48M	-145.11M	-44.15M	-164.84M	-

Cash Flow

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	42.24M	70.32M	97.56M	137.61M	70.51M	-60.13M	-111.31M	56.84M	131.24M	161.87M
Investing Cash Flow	-42.86M	-335.91M	162.60M	-178.09M	-120.25M	-186.59M	-88.93M	-193.04M	-89.46M	-
Financing Cash Flow	-16.00M	329.46M	7.42M	304.35M	-43.12M	-9.43M	116.86M	122.32M	61.47M	-
Capital Expenditure	44.32M	76.25M	98.87M	180.04M	112.78M	158.45M	110.76M	67.67M	70.02M	45.80M
Free Cash Flow	-2.08M	-5.93M	-1.31M	-42.44M	-42.27M	-218.58M	-222.07M	-10.83M	61.22M	116.07M
Dividends Paid	16.00M	9.00M	41.33M	41.33M	41.00M	29.44K	940.06K	2.01M	4.11M	4.19M
FCF to OCF	-4.92%	-8.43%	-1.35%	-30.84%	-59.95%	363.50%	199.51%	-19.05%	46.65%	71.71%
Dividend Paid to FCF	-769.59%	-151.73%	-3149.61%	-97.39%	-97.00%	-0.01%	-0.42%	-18.53%	6.71%	3.61%

Earnings

Report Date	Mar 30, 2020	Apr 30, 2020	Aug 21, 2020	Oct 29, 2020	Feb 25, 2021	Apr 28, 2021	Aug 24, 2021	Oct 28, 2021	Feb 25, 2022	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Apr 26, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.06	0.02	0.06	0.04	-0.07	-0.10	-0.10	-0.07	-0.05	-0.07	-0.10	-0.09	-0.13	-0.04
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	Pre-market	Pre-market	-	-	-	-	Pre-market

Key Statistics & Ratios

Market Cap6.21B

Enterprise Value6.31B

Trailing P/E74.35

Forward P/E0.00

Price / Sales10.54

Price / Book6.61

EPS0.20

Book Value2.39

Revenue (TTM)589.57M

Gross Profit (TTM)395.93M

EBITDA159.42M

Profit Margin14.21%

Operating Margin20.86%

Return on Equity9.00%

Return on Assets4.64%

Shares Outstanding417.95M

Shares Float294.36M

Beta0.59

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20201×

0.10Jul 10, 2020